San Francisco-area BioEconomy Initiative plans to speed drug development

11/12/2013 | Xconomy

Backers of the Bay Area BioEconomy Initiative plan to coordinate Northern California biotech community efforts to accelerate clinical trials and drug discovery, brainstorm ways to meet patient needs, and integrate digital technologies into routine medical practice. Una Ryan will serve as chairwoman, and backers include Deloitte, Amgen unit Onyx, BayBio, Agilent Technologies, Alta Partners, Bayer, BioCentury Publications, DLA Piper, the Gladstone Institutes, Johnson & Johnson, Oncomed, Pfizer, Stanford University, and the University of California, San Francisco.

View Full Article in:

Xconomy

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY